Now we know why many great Biotech minds have joined Anp...The recent Data is superb giving hope to many DMD sufferers and also the new indications to follow....Market for Inflammation is $1.1 Billion...
Its safe to say Atl1102 will have a market well over $200 billion..
Is Anp the next CSL..... I say YES $$
Ann: US FDA Type C Meeting for ATL1102 in DMD, page-17
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.008(8.25%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 9.8¢ | 11.0¢ | 9.8¢ | $360.4K | 3.457M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 248759 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |